Step complete
Step complete
Step complete

Cwm Taf Morgannwg University Health Board (CTMUHB), Digipharm, Roche Diagnostics and Life Sciences Hub Wales are collaborating to develop and assess a pioneering value-based procurement approach that delivers value and outcomes that matter for patients and healthcare staff. This will focus on adapting existing approaches to diagnosing heart failure patients and developing processes that will inform procurement decisions. The heart failure diagnosis test investigated is NTproBNP, a simple and quick blood test that measures the number of proteins the heart produces when facing stress.

All partners will work closely throughout the project, which will be delivered within CTMUHB where clinical, procurement, operational and informatics teams will be supporting.

Roche is manufacturing and providing NTproBNP, alongside quality improvement support and procurement input into the project.

 The project is utilising Digipharm’s outcome-based smart contracting platform to gather and manage outcome data which will provide decision support information to clinicians and procurement teams.

Life Sciences Hub Wales is offering project management and communications support.

For more information about the project, please get in touch by emailing hello@lshubwales.com

Health Board
  • Cwm Taf Morgannwg University Health Board
Partners / funding sources

Digipharm, Roche Diagnostics, Life Sciences Hub Wales

Start date
  • Updates
  • Outcomes
Completed

10th November 2021

Project launches at Value in Health Week 2021

Health Boards can improve patient management and outcomes if they improve the use of NTproBNP. However, CTMUHB do not currently have a consistent approach for using NTproBNP, therefore its use across the Health Board is varied.

To help tackle this, we need to fully understand patient pathways, workforce and referral, and medical training support within the context of using NTproBNP. This will help create a more sustainable evidenced approach to procurement, including understanding how NTproBNP testing is currently being used within the chronic heart failure pathway.

The end of the project will see a proposed collaborative purchasing approach for NTProBNP’s long-term implementation, which will be underpinned by CTMUHB data and an outcome based contracting agreement. This information could then act as best practice for other departments and Health Boards wishing to incorporate sustainable value-based procurement into their workflows.